Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial.

Adam G StewartAndrew HendersonMichelle J BauerDavid L Paterson Patrick N A Harris

Published in: JAC-antimicrobial resistance (2021)

activity against ceftriaxone-resistant Enterobacterales bloodstream isolates and may be a suitable agent to be trialled for treatment of serious infections due to these organisms.

Keyphrases

klebsiella pneumoniae
escherichia coli
multidrug resistant
gram negative
clinical trial
randomized controlled trial
phase ii
staphylococcus aureus
cystic fibrosis
combination therapy
smoking cessation